7-45920948-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000598.5(IGFBP3):c.193C>T(p.Pro65Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000036 in 1,388,332 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000032 ( 0 hom. )
Consequence
IGFBP3
NM_000598.5 missense
NM_000598.5 missense
Scores
6
9
4
Clinical Significance
Conservation
PhyloP100: 8.19
Genes affected
IGFBP3 (HGNC:5472): (insulin like growth factor binding protein 3) This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGFBP3 | NM_000598.5 | c.193C>T | p.Pro65Ser | missense_variant | 1/5 | ENST00000613132.5 | NP_000589.2 | |
IGFBP3 | NM_001013398.2 | c.193C>T | p.Pro65Ser | missense_variant | 1/5 | NP_001013416.1 | ||
IGFBP3 | XM_047420325.1 | c.193C>T | p.Pro65Ser | missense_variant | 1/4 | XP_047276281.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGFBP3 | ENST00000613132.5 | c.193C>T | p.Pro65Ser | missense_variant | 1/5 | 5 | NM_000598.5 | ENSP00000477772.2 | ||
IGFBP3 | ENST00000381083.9 | c.193C>T | p.Pro65Ser | missense_variant | 1/5 | 5 | ENSP00000370473.4 | |||
IGFBP3 | ENST00000381086.9 | c.10-108C>T | intron_variant | 2 | ENSP00000370476.4 | |||||
IGFBP3 | ENST00000448817.1 | c.73+679C>T | intron_variant | 4 | ENSP00000389668.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151730Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151730
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000323 AC: 4AN: 1236602Hom.: 0 Cov.: 31 AF XY: 0.00000330 AC XY: 2AN XY: 606032
GnomAD4 exome
AF:
AC:
4
AN:
1236602
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
606032
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151730Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74114
GnomAD4 genome
AF:
AC:
1
AN:
151730
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74114
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.193C>T (p.P65S) alteration is located in exon 1 (coding exon 1) of the IGFBP3 gene. This alteration results from a C to T substitution at nucleotide position 193, causing the proline (P) at amino acid position 65 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;D;.;T
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;M;M;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;D;D;.
REVEL
Uncertain
Sift
Uncertain
.;D;D;.
Sift4G
Uncertain
D;D;D;D
Polyphen
0.99
.;D;.;.
Vest4
MutPred
0.60
.;Gain of glycosylation at P65 (P = 0.0093);Gain of glycosylation at P65 (P = 0.0093);.;
MVP
MPC
1.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at